SIGA stock gains amid EU talks to buy monkeypox therapeutics, vaccines (NASDAQ:SIGA)
seekingalpha.com
finance
2022-05-27 13:27:58

blackdovfx/iStock via Getty Images The European Union in talks to form a common purchasing agreement for vaccines and antivirals against monkeypox, as the rare viral disease makes a comeback in countries outside Africa where its cases are usually found. Discussions are underway to buy Imvanex vaccine developed by Danish biotech Bavarian Nordic (OTCPK:BVNKF) (OTCPK:BVNRY) and tecovirimat antiviral developed by U.S.-based SIGA Technologies (NASDAQ:SIGA), Swedish daily Dagens Nyheter reported citing Sweden's vaccine coordinator Richard Bergstrom.
